M&A
Page 47 of 100
HealthNovartis Is Paying $2.1 Billion for Endocyte, a Company That’s Developing a New Prostate Cancer Treatment
By David MeyerOctober 18, 2018

By BloombergOctober 16, 2018

By BloombergOctober 11, 2018

By Sy MukherjeeOctober 10, 2018

By Kevin KelleherOctober 3, 2018

By Kevin KelleherSeptember 28, 2018

By Kevin KelleherSeptember 26, 2018

RetailGrubhub Just Bought This College Startup for $150 Million, Firing the Latest Shot in the Food Delivery Wars
By Brittany ShootSeptember 26, 2018

By Kevin KelleherSeptember 24, 2018

By BloombergSeptember 24, 2018

By Aaron PressmanSeptember 21, 2018

By Aaron Pressman and Adam LashinskySeptember 21, 2018
Most Popular





